Table 1.
Characteristics of patients with COVID19 and controls.
Variables | Controls (n = 50) | Mild-Moderate (n = 50) | Severe (n = 50) | Total (n = 150) | P-value |
---|---|---|---|---|---|
Age (years) | |||||
Mean ± SD | 37.4 ± 7.7 | 40.0 ± 11.9 | 45.9 ± 11.2 | 41.1 ± 0.9 | <0.001 |
Median [IQR] | 38 [33–42] | 40 [32–51] | 47 [35–55]a | 40 [34–49] | |
Sex n (%) | |||||
F | 2 (4.0) | 8 (16.0) | 1 (2.0) | 11 (7.3) | 0.02 |
M | 48 (96.0) | 42 (84.0) | 49 (98.0) | 139 (92.7) | |
Ethnicity n (%) | |||||
Indian subcontinent | 43 (86.0) | 30 (60.0) | 33 (66.0) | 106 (70.7) | 0.04 |
Middle East North Africa | 5 (10.0) | 15 (30.0) | 10 (20.0) | 30 (20.0) | |
Others | 2 (4.0) | 5 (10.0) | 7 (14.0) | 14 (9.3) | |
BMI (kg/m2) | |||||
Mean ± SD | 25.4 ± 4.0 | 26.5 ± 3.9 | 29.7 ± 6.1 | 27.2 ± 0.4 | <0.001 |
Median [IQR] | 24 [23–27] | 26 [23–28] | 28 [26–33]a, b | 26 [24–29] | |
Obesity Level n (%) | |||||
Normal (≤25) | 28 (56.0) | 20 (40.0) | 7 (14.0) | 55 (36.7) | <0.001 |
Overweight (25–30) | 17 (34.0) | 21 (42.0) | 25 (50.0) | 63 (42.0) | |
Obese (30+) | 5 (10.0) | 9 (18.0) | 18 (36.0) | 32 (21.3) | |
Heart rate (beats per minute) | |||||
Mean ± SD | 76.5 ± 10.0 | 89.8 ± 16.1 | 102.4 ± 16.3 | 89.3 ± 1.5 | <0.001 |
Median [IQR] | 78 [70–82] | 86 [78–104]b | 100 [88–117]a, b | 86 [78–100] | |
SpO2 (%) | |||||
Mean ± SD | 98.7 ± 0.8 | 98.2 ± 2.1 | 93.6 ± 6.9 | 79.2 ± 0.8 | <0.001 |
Median [IQR] | 99 [98–99] | 99 [97–100]b | 96 [91–97]a, b | 78 [72–86] | |
SBP (mmHg) | |||||
Mean ± SD | 122.5 ± 10.3 | 131.1 ± 17.7 | 125.5 ± 17.6 | 126.4 ± 1.3 | 0.02 |
Median [IQR] | 121 [116–130] | 129 [119–139]a | 128 [109–137] | 126 [116–135] | |
DBP (mmHg) | |||||
Mean ± SD | 77.9 ± 7.4 | 80.2 ± 9.1 | 79.5 ± 12.6 | 79.2 ± 0.8 | 0.50 |
Median [IQR] | 78 [73–81] | 81 [74–88] | 78 [71–86] | 78 [72–86] |
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure.
aSignificantly different compared to control subjects.
bSignificantly different compared to Mild-Moderate subjects.